BIOTRONIK Neuro Launches AI-Powered Embrace One Platform
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace OneĀ® Proactive Intelligence, a proprietary artificial intelligence (AI)...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace OneĀ® Proactive Intelligence, a proprietary artificial intelligence (AI)...
MORGES, Switzerland, July 20, 2026 Spectrum Dynamics Medical has announced the launch of the All-Energy Enhancement for its FDA-cleared,...
ROCKVILLE, Md. & SHANGHAI, July 20, 2026 AbelZeta Pharma, Inc. has achieved a significant regulatory milestone after the European...
SHANGHAI, China & NEW YORK, July 20, 2026 Argo Biopharma has announced the successful dosing of the first participant...
SAN ANTONIO, July 20, 2026 Valion Bio, Inc. has announced a significant clinical development milestone after Sheba Medical Center,...
MUMBAI, India & NAPLES, Fla., July 21, 2026 Lupin Limited has announced the strategic spin-out of two promising clinical-stage...
SYDNEY, Australia & INCHEON, South Korea, July 16, 2026 Organon and Samsung Bioepis have expanded their longstanding partnership through...
SALT LAKE CITY, July 20, 2026 ARUP Laboratories has introduced ARUP CLARISPECT⢠Multiple Myeloma MRD by Spectral Flow Cytometry,...
HONG KONG, July 20, 2026 Akeso, Inc. has announced a significant milestone in its oncology pipeline with the first...
VALBY, Denmark, July 20, 2026 H. Lundbeck A/S has reached a major clinical development milestone with the last patient...
